Former President Joe Biden announced this weekend that he has been diagnosed with an aggressive form of prostate cancer, the second leading cause of cancer death for men in the United States. About 1 ...

One test could have prevented terminal prostate cancer, says patient - Research has shown that the use of the PSA test varies ...

Former President Joe Biden has been diagnosed with an "aggressive" form of prostate cancer that has spread to his bones. But what does it mean for this type of cancer to be called aggressive? As a ...

Black individuals in the United States continue to experience the highest rates of prostate cancer diagnosis and death. Even though the prostate-specific antigen (PSA) test, a validated diagnostic ...

Talzenna plus Xtandi showed a 14-month survival improvement for HRR gene-mutated metastatic castration-resistant prostate cancer, supported by TALAPRO-2 trial data. Nubeqa approval for metastatic ...

A newly expanded prostate cancer drug could bring new hope to patients with a common form of the disease. Novartis, a Switzerland-based pharmaceutical company, announced on March 28 that the U.S. Food ...

The PROSTATE-IQ trial uses the ArteraAI Prostate Test to personalize treatment for prostate cancer recurrence post-prostatectomy, potentially reducing hormone therapy use. The trial stratifies ...

I am a prostate cancer patient and a board-certified health care chaplain. I’ve served patients from every end of the spectrum. And I’m living with hormone-sensitive, high-grade (Gleason 9) prostate ...

GRAND RAPIDS, Mich. — One in eight men will be diagnosed with prostate cancer in their lifetime. Typically, treatment includes hormone medication, and when that fails, chemotherapy. BAMF Health in ...

That’s because most cases are caught before the cancer has spread. In fact, more than 75% of diagnoses are made while the disease is still confined to the prostate. When that happens, the outlook is ...